1. Home
  2. GIPR vs EVGN Comparison

GIPR vs EVGN Comparison

Compare GIPR & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Generation Income Properties Inc.

GIPR

Generation Income Properties Inc.

N/A

Current Price

$0.43

Market Cap

558.8K

Sector

Real Estate

ML Signal

N/A

Logo Evogene Ltd

EVGN

Evogene Ltd

N/A

Current Price

$0.43

Market Cap

11.1M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GIPR
EVGN
Founded
2015
1999
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Agricultural Chemicals
Sector
Real Estate
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
558.8K
11.1M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
GIPR
EVGN
Price
$0.43
$0.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 11.2M
251.9K
Earning Date
11-16-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $9,739,942.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.20
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.11
$0.35
52 Week High
$1.99
$1.50

Technical Indicators

Market Signals
Indicator
GIPR
EVGN
Relative Strength Index (RSI) 52.56 33.69
Support Level $0.23 $0.37
Resistance Level $0.79 $0.84
Average True Range (ATR) 0.16 0.05
MACD -0.00 -0.01
Stochastic Oscillator 13.80 21.53

Price Performance

Historical Comparison
GIPR
EVGN

About GIPR Generation Income Properties Inc.

Generation Income Properties Inc is an internally managed real estate investment trust focused on acquiring and managing income-producing retail, office, and industrial properties net leased to high-quality tenants in different states throughout the United States. Its key source of revenue is the rental income. The trust's properties are generally net leased to a single tenant.

About EVGN Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.

Share on Social Networks: